ARTIFICIAL INTELLIGENCE DRUG R&D MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET

7.1 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 IBM Watson

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2

16.3 QuantumBlack

16.4

16.5 Gatehouse Bio

16.6

16.7 BioXel

16.8

16.9 Cyclica Inc

16.10

16.11 Insilico Medicine

16.12

16.13 Phenomic AI

16.14

16.15 Genpact Cora

16.16

16.17 Google DeepMind

16.18

16.19 Nq Medical

16.20

16.21 Palantir Technologies

16.22

16.23 Among other players domestic and global Artificial Intelligence Drug R&D market share data is available for global North America Europe Asia-Pacific Middle East & Africa and South America separately Our analysts understand competitive strengths and provide competitive analysis for each competitor separately

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER